MicroRNAs in NF-κB signaling

Journal of Molecular Cell Biology

Volumn 3, Issue 3, 2011, Pages 159-166

  Ma, Xiaodong ^a   Becker Buscaglia, Lindsey E ^a   Barker, Juanita R ^a   Li, Yong ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

cancer; microRNA; NF B

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA;

ANIMAL; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; GENE EXPRESSION REGULATION; HUMANS; MICRORNAS; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 79958225650     PISSN: 16742788     EISSN: 17594685     Source Type: Journal    
DOI: 10.1093/jmcb/mjr007     Document Type: Review

References (96)

1. Annunziata, C.M., Davis, R.E., Demchenko, Y., et al. (2007). Frequent engagement of the classical and alternative NF-kB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell 12, 115-130. (Pubitemid 47199123)
2. Aqeilan, R.I., Calin, G.A., and Croce, C.M. (2010). miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ. 17, 215-220.
3. Baek, D., Villen, J., Shin, C., et al. (2008). The impact of microRNAs on protein output. Nature 455, 64-71.
4. Bala, S., Marcos, M., Kodys, K., et al. (2011). Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor a (TNFa) production via increased mRNA half-life in alcoholic liver disease. J. Biol. Chem. 286, 1436-1444.
5. Baud, V., and Karin, M. (2009). Is NF-kB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 8, 33-40.
6. Bazzoni, F., Rossato, M., Fabbri, M., et al. (2009). Induction and regulatory function of miR-9 in human monocytes and neutrophils exposed to proinflammatory signals. Proc. Natl. Acad. Sci. USA 106, 5282-5287.
7. Bharti, A.C., and Aggarwal, B.B. (2002). Chemopreventive agents induce suppression of nuclear factor-kB leading to chemosensitization. Ann. NY Acad. Sci. 973, 392-395. (Pubitemid 36125041)
8. Bhaumik, D., Scott, G.K., Schokrpur, S., et al. (2008). Expression of microRNA-146 suppresses NF-kB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27, 5643-5647.
9. Bonci, D., Coppola, V., Musumeci, M., et al. (2008). The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat. Med. 14, 1271-1277.
10. Borralho, P.M., Kren, B.T., Castro, R.E., et al. (2009). MicroRNA-143 reduces viability and increases sensitivity to 5-fluorouracil in HCT116 human colorectal cancer cells. FEBS J. 276, 6689-6700.
11. Cervigne, N.K., Reis, P.P., Machado, J., et al. (2009). Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum. Mol. Genet. 18, 4818-4829.
12. Chen, R., Alvero, A.B., Silasi, D.A., et al. (2008). Regulation of IKKb by miR-199a affects NF-kB activity in ovarian cancer cells. Oncogene 27, 4712-4723.
13. Conti, A., Aguennouz, M.H., La Torre, D., et al. (2009). miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J. Neuro-Oncol. 93, 325-332.
14. Costinean, S., Zanesi, N., Pekarsky, Y., et al. (2006). Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Em-miR155 transgenic mice. Proc. Natl. Acad. Sci. USA 103, 7024-7029.
15. Eis, P.S., Tam, W., Sun, L., et al. (2005). Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc. Natl. Acad. Sci. USA 102, 3627-3632. (Pubitemid 40354662)
16. Elmen, J., Lindow, M., Schutz, S., et al. (2008). LNA-mediated microRNA silencing in non-human primates. Nature 452, 896-899. (Pubitemid 351550859)
17. Feng, X., Guo, Z., Nourbakhsh, M., et al. (2002). Identification of a negative response element in the human inducible nitric-oxide synthase (hiNOS) promoter: the role of NF-kB-repressing factor (NRF) in basal repression of the hiNOS gene. Proc. Natl. Acad. Sci. USA 99, 14212-14217. (Pubitemid 35257651)
18. Froese, N., Schwarzer, M., Niedick, I., et al. (2006). Innate immune responses in NF-kB-repressing factor-deficient mice. Mol. Cell. Biol. 26, 293-302.
19. Fulci, V., Chiaretti, S., Goldoni, M., et al. (2007). Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia. Blood 109, 4944-4951. (Pubitemid 46827793)
20. Gironella, M., Seux, M., Xie, M.-J., et al. (2007). Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development. Proc. Natl. Acad. Sci. USA 104, 16170-16175. (Pubitemid 350099380)
21. Greither, T., Grochola, L.F., Udelnow, A., et al. (2010). Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Intl. J. Cancer 126, 73-80.
22. Guo, L.M., Pu, Y., Han, Z., et al. (2009). MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kB1. FEBS J. 276, 5537-5546.
23. Guo, H., Ingolia, N.T., Weissman, J.S., et al. (2010). Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466, 835-840.
24. Hafner, M., Landthaler, M., Burger, L., et al. (2010). Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 141, 129-141.
25. Hatley, M.E., Patrick, D.M., Garcia, M.R., et al. (2010). Modulation of K-Ras-dependent lung tumorigenesis by microRNA-21. Cancer Cell 18, 282-293.
26. Huang, H., Xie, C., Sun, X., et al. (2010). miR-10a contributes to retinoid acidinduced smooth muscle cell differentiation. J. Biol. Chem. 285, 9383-9389.
27. Hurst, D.R., Edmonds, M.D., Scott, G.K., et al. (2009). Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 69, 1279-1283.
28. Iliopoulos, D., Hirsch, H.A., and Struhl, K. (2009). An epigenetic switch involving NF-kB, Lin28, let-7 microRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706.
29. Iliopoulos, D., Jaeger, S.A., Hirsch, H.A., et al. (2010). STAT3 activation of miR-21 and miR-181b-1 via PTEN and CYLD are part of the epigenetic switch linking inflammation to cancer. Mol. Cell 39, 493-506.
30. Imaizumi, T., Tanaka, H., Tajima, A., et al. (2010). IFN-g and TNF-a synergistically induce microRNA-155 which regulates TAB2/IP-10 expression in human mesangial cells. Am. J. Nephrol. 32, 462-468.
31. Inoue, J., Gohda, J., Akiyama, T., et al. (2007). NF-kB activation in development and progression of cancer. Cancer Sci. 98, 268-274. (Pubitemid 46195594)
32. Iorio, M.V., Ferracin, M., Liu, C.-G., et al. (2005). MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 65, 7065-7070. (Pubitemid 41161233)
33. Jiang, J., Gusev, Y., Aderca, I., et al. (2008). Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res. 14, 419-427. (Pubitemid 351226109)
34. Jones, S., Zhang, X., Parsons, D.W., et al. (2008). Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801-1806.
35. Jongen-Lavrencic, M., Sun, S.M., Dijkstra, M.K., et al. (2008). MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 111, 5078-5085.
36. Karin, M. (2006). Nuclear factor-kB in cancer development and progression. Nature 441, 431-436. (Pubitemid 44050137)
37. Karin, M., and Greten, F.R. (2005). NF-kB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 5, 749-759. (Pubitemid 41400849)
38. Karin, M., Cao, Y., Greten, F.R., et al. (2002). NF-kB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2, 301-310. (Pubitemid 37328783)
39. Keats, J.J., Fonseca, R., Chesi, M., et al. (2007). Promiscuous mutations activate the noncanonical NF-kB pathway in multiple myeloma. Cancer Cell 12, 131-144. (Pubitemid 47208626)
40. Kluiver, J., Poppema, S., de Jong, D., et al. (2005). BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas. J. Pathol. 207, 243-249. (Pubitemid 41404155)
41. Kluiver, J., van den Berg, A., de Jong, D., et al. (2007). Regulation of pri-microRNA BIC transcription and processing in Burkitt lymphoma. Oncogene 26, 3769-3776. (Pubitemid 46878126)
42. Krutzfeldt, J., Rajewsky, N., Braich, R., et al. (2005). Silencing of microRNAs in vivo with 'antagomirs'. Nature 438, 685-689.
43. Lam, L.T., Davis, R.E., Ngo, V.N., et al. (2008). Compensatory IKKa activation of classical NF-kB signaling during IKKb inhibition identified by an RNA interference sensitization screen. Proc. Natl. Acad. Sci. USA 105, 20798-20803.
44. Lawrie, C.H., Soneji, S., Marafioti, T., et al. (2007). MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 121, 1156-1161. (Pubitemid 47101656)
45. Lee, E.J., Gusev, Y., Jiang, J., et al. (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int. J. Cancer 120, 1046-1054. (Pubitemid 46214304)
46. Lenz, G., Davis, R.E., Ngo, V.N., et al. (2008). Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science 319, 1676-1679. (Pubitemid 351432507)
47. Li, T., Morgan, M.J., Choksi, S., et al. (2010a). MicroRNAs modulate the noncanonical transcription factor NF-kB pathway by regulating expression of the kinase IKKa during macrophage differentiation. Nat. Immunol. 11, 799-805.
48. Li, Y., Vandenboom, T.G., 2nd, Wang, Z., et al. (2010b). miR-146a suppresses invasion of pancreatic cancer cells. Cancer Res. 70, 1486-1495.
49. Lindenblatt, C., Schulze-Osthoff, K., and Totzke, G. (2009). IkBz expression is regulated by miR-124a. Cell Cycle 8, 2019-2023.
50. Liu, M.F., Jiang, S., Lu, Z., et al. (2010a). Physiological and pathological functions of mammalian microRNAs. In: McQueen, C.A. (ed). Comprehensive Toxicology, 2nd edn. London: Elsevier Science, 427-446.
51. Liu, S., Wu, L.C., Pang, J., et al. (2010b). Sp1/NFkB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 17, 333-347.
52. Lovis, P., Roggli, E., Laybutt, D.R., et al. (2008). Alterations in microRNA expression contribute to fatty acid-induced pancreatic b-cell dysfunction. Diabetes 57, 2728-2736.
53. Lu, Z., Liu, M., Stribinskis, V., et al. (2008). MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 27, 4373-4379. (Pubitemid 352010003)
54. Lu, Z., Li, Y., Takwi, A., et al. (2011). miR-301a as an NF-kB activator in pancreatic cancer cells. EMBO J. 30, 57-67.
55. Lukiw, W.J., Zhao, Y., and Cui, J.G. (2008). An NF-kB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J. Biol. Chem. 283, 31315-31322.
56. Marquez, R.T., Wendlandt, E., Galle, C.S., et al. (2010). MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets pellino-1, and inhibits NF-kB signaling. Am. J. Physiol. Gastroint. Liver Physiol. 298, G535-G541.
57. Medina, P.P., Nolde, M., and Slack, F.J. (2010). OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 467, 86-90.
58. Mott, J.L., Kurita, S., Cazanave, S.C., et al. (2010). Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kB. J. Cell Biochem. 110, 1155-1164.
59. Navarro, A., Gaya, A., Martinez, A., et al. (2008). MicroRNA expression profiling in classic Hodgkin lymphoma. Blood 111, 2825-2832.
60. Nikiforova, M.N., Tseng, G.C., Steward, D., et al. (2008). MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J. Clin. Endocrinol. Metab. 93, 1600-1608. (Pubitemid 351656494)
61. Nourbakhsh, M., and Hauser, H. (1999). Constitutive silencing of IFN-b promoter is mediated by NRF (NF-kB-repressing factor), a nuclear inhibitor of NF-kB. EMBO J. 18, 6415-6425. (Pubitemid 29533245)
62. Nourbakhsh, M., Kalble, S., Dorrie, A., et al. (2001). The NF-kB repressing factor is involved in basal repression and interleukin (IL)-1-induced activation of IL-8 transcription by binding to a conserved NF-kB-flanking sequence element. J. Biol. Chem. 276, 4501-4508.
63. O'Connell, R.M., Taganov, K.D., Boldin, M.P., et al. (2007). MicroRNA-155 is induced during the macrophage inflammatory response. Proc. Natl. Acad. Sci. USA 104, 1604-1609. (Pubitemid 46214637)
64. Pacifico, F., Crescenzi, E., Mellone, S., et al. (2010). Nuclear factor-kB contributes to anaplastic thyroid carcinomas through up-regulation of miR-146a. J. Clin. Endocrinol. Metab. 95, 1421-1430.
65. Patrick, D.M., Montgomery, R.L., Qi, X., et al. (2010). Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice. J. Clin. Inves. 120, 3912-3916.
66. Pecot, C.V., Calin, G.A., Coleman, R.L., et al. (2011). RNA interference in the clinic: challenges and future directions. Nat. Rev. Cancer 11, 59-67.
67. Perry, M.M., Moschos, S.A., Williams, A.E., et al. (2008). Rapid changes in microRNA-146a expression negatively regulate the IL-1b-induced inflammatory response in human lung alveolar epithelial cells. J. Immunol. 180, 5689-5698.
68. Rai, D., Karanti, S., Jung, I., et al. (2008). Coordinated expression of microRNA-155 and predicted target genes in diffuse large B-cell lymphoma. Cancer Genet. Cytogenet. 181, 8-15. (Pubitemid 351192031)
69. Roggli, E., Britan, A., Gattesco, S., et al. (2010). Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic b-cells. Diabetes 59, 978-986.
70. Ryseck, R.P., Novotny, J., and Bravo, R. (1995). Characterization of elements determining the dimerization properties of RelB and p50. Mol. Cell. Biol. 15, 3100-3109.
71. Sarkar, F.H., Banerjee, S., and Li, Y. (2007). Pancreatic cancer: pathogenesis, prevention and treatment. Toxicol. Appl. Pharmacol. 224, 326-336. (Pubitemid 47575667)
72. Schetter, A.J., Leung, S.Y., Sohn, J.J., et al. (2008). MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. J. Am. Med. Assoc. 299, 425-436. (Pubitemid 351185951)
73. Sheedy, F.J., Palsson-McDermott, E., Hennessy, E.J., et al. (2010). Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat. Immunol. 11, 141-147.
74. Shi, L., Cheng, Z., Zhang, J., et al. (2008). hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res. 1236, 185-193.
75. Shin, V.Y., Jin, H., Ng, E.K., et al. (2011). NF-kB targets miR-16 and miR-21 in gastric cancer: involvement of prostaglandin E receptors. Carcinogenesis 32, 240-245.
76. Su, J.L., Chen, P.B., Chen, Y.H., et al. (2010). Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Cancer Res. 70, 5096-5108.
77. Suzuki, Y., Kim, H.W., Ashraf, M., et al. (2010). Diazoxide potentiates mesenchymal stem cell survival via NF-kB-dependent miR-146a expression by targeting Fas. Am. J. Physiol. Heart Circ. Physiol. 299, H1077-H1082.
78. Taganov, K.D., Boldin, M.P., Chang, K.-J., et al. (2006). NF-kB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc. Natl. Acad. Sci. USA 103, 12481-12486. (Pubitemid 44267285)
79. Thompson, R.C., Herscovitch, M., Zhao, I., et al. (2011). NF-kB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway. J. Biol. Chem. 286, 1675-1682.
80. Tili, E., Michaille, J.J., Cimino, A., et al. (2007). Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-a stimulation and their possible roles in regulating the response to endotoxin shock. J. Immunol. 179, 5082-5089.
81. Trompouki, E., Hatzivassiliou, E., Tsichritzis, T., et al. (2003). CYLD is a deubiquitinating enzyme that negatively regulates NF-kB activation by TNFR family members. Nature 424, 793-796. (Pubitemid 37021710)
82. van den Berg, A., Kroesen, B.J., Kooistra, K., et al. (2003). High expression of B-cell receptor inducible gene BIC in all subtypes of Hodgkin lymphoma. Genes Chromosomes Cancer 37, 20-28. (Pubitemid 36417918)
83. Vigorito, E., Perks, K.L., Abreu-Goodger, C., et al. (2007). MicroRNA-155 regulates the generation of immunoglobulin class-switched plasma cells. Immunity 27, 847-859. (Pubitemid 350258623)
84. Wan, H.Y., Guo, L.M., Liu, T., et al. (2010). Regulation of the transcription factor NF-kB1 by microRNA-9 in human gastric adenocarcinoma. Mol. Cancer 9, 16-20.
85. Wang, H., Garzon, R., Sun, H., et al. (2008). NF-kB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 14, 369-381.
86. Wang, B., Majumder, S., Nuovo, G., et al. (2009). Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology 50, 1152-1161.
87. Wang, Q., Sun, Z.X., Allgayer, H., et al. (2010). Downregulation of E-cadherin is an essential event in activating beta-catenin/Tcf-dependent transcription and expression of its target genes in Pdcd4 knockdown cells. Oncogene 29, 128-138.
88. Williams, A.E., Perry, M.M., Moschos, S.A., et al. (2008). Role of miRNA-146a in the regulation of the innate immune response and cancer. Biochem. Soc. Trans. 36, 1211-1215.
89. Xiao, B., Liu, Z., Li, B.S., et al. (2009). Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J. Infect. Dis. 200, 916-925.
90. Yachida, S., Jones, S., Bozic, I., et al. (2010). Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114-1117.
91. Yanaihara, N., Caplen, N., Bowman, E., et al. (2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9, 189-198. (Pubitemid 43357945)
92. Yin, G., Chen, R., Alvero, A.B., et al. (2010). TWISTing stemness, inflammation and proliferation of epithelial ovarian cancer cells through miR199A2/214. Oncogene 29, 3545-3553.
93. Young, M.R., Santhanam, A.N., Yoshikawa, N., et al. (2010). Have tumor suppressor PDCD4 and its counteragent oncogenic miR-21 gone rogue? Mol. Interv. 10, 76-79.
94. Zhang, X., Liu, S., Hu, T., et al. (2009). Up-regulated microRNA-143 transcribed by nuclear factor kB enhances hepatocarcinoma metastasis by repressing fibronectin expression. Hepatology 50, 490-499.
95. Zhou, R., Hu, G., Liu, J., et al. (2009). NF-kB p65-dependent transactivation of miRNA genes following cryptosporidium parvum infection stimulates epithelial cell immune responses. PLoS Pathog. 5, 100-681.
96. Zhou, R., Hu, G., Gong, A.Y., et al. (2010). Binding of NF-kB p65 subunit to the promoter elements is involved in LPS-induced transactivation of miRNA genes in human biliary epithelial cells. Nucleic Acids Res. 38, 3222-3232.